Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Jan, Freijer"'
Autor:
Michael Gautrois, Jens Rengelshausen, Anna Dari, Stefan Buller, Hans-Jürgen Stahlberg, Jan Freijer
Publikováno v:
Clinical Pharmacokinetics. 60:785-794
Understanding the effect of oxycodone pharmacokinetics (PK) on µ-opioid receptor binding benefits from an integrated approach to compiling the results of multiple studies. The current pharmacokinetic/pharmacodynamic (PK/PD) model analysis brings tog
Autor:
Thomas M. Tzschentke, Estelle Watson, Feras Khalil, Claudia Lefeber, Jan Freijer, Mariëlle Eerdekens, Siak Leng Choi
Publikováno v:
Journal of Pain Research. 13:3107-3123
Objective The main aim of this analysis was to characterize the pharmacokinetics (PK) of tapentadol in pediatric patients from birth to
Autor:
Akash Khandelwal, John N. van den Anker, Mariëlle Eerdekens, Jan Freijer, Claudia Lefeber, Estelle Watson
Publikováno v:
Journal of Pain Research. 12:2835-2850
Objective The main aim of this analysis was to characterize the pharmacokinetics (PK) of the strong analgesic tapentadol in 2-year-old to
Autor:
Feras, Khalil, Siak Leng, Choi, Estelle, Watson, Thomas M, Tzschentke, Claudia, Lefeber, Mariëlle, Eerdekens, Jan, Freijer
Publikováno v:
Journal of Pain Research
Objective The main aim of this analysis was to characterize the pharmacokinetics (PK) of tapentadol in pediatric patients from birth to
Autor:
Jules A. A. C. Heuberger, Jan Freijer, Paul D. Morrison, Olubukayo-Opeyemi Oyetayo, Zheng Guan, Tim L. Beumer, Adam F. Cohen, Linda E. Klumpers, Joop M. A. van Gerven
Publikováno v:
Clinical Pharmacokinetics, 54(2), 209-219
Δ(9)-Tetrahydrocannobinol (THC), the main psychoactive compound of Cannabis, is known to have a long terminal half-life. However, this characteristic is often ignored in pharmacokinetic (PK) studies of THC, which may affect the accuracy of predictio
Publikováno v:
International Journal of Methods in Psychiatric Research. 23:245-256
The subjective effects of cannabis and its main psychoactive component Δ9-tetrahydrocannabinol (THC) have played an important part in determining the therapeutic potential of cannabinoid agonists and antagonists. The effects mainly consist of feelin
Autor:
Jacobus Burggraaf, Rám N. Sukhai, Boudewijn Bakker, Adam F. Cohen, H M Reeser, P Hu, Erica S. Klaassen, Richard H. Klein, B E P B Ballieux, Wilma Oostdijk, Ricardo Alvarez-Jimenez, J.M. Wit, Jan Freijer
Publikováno v:
Hormone Research in Paediatrics, 79(5), 300-309
Klein, R H, Alvarez-Jimenez, R, Sukhai, R N, Oostdijk, W, Bakker, B, Reeser, H M, Ballieux, B E P B, Hu, P, Klaassen, E S, Freijer, J, Burggraaf, J, Cohen, A F & Wit, J M 2013, ' Pharmacokinetics and pharmacodynamics of orally administered clonidine : A model-based approach ', Hormone Research in Paediatrics, vol. 79, no. 5, pp. 300-309 . https://doi.org/10.1159/000350819
Hormone Research in Paediatrics, 79(5), 300-309. S. Karger AG
Klein, R H, Alvarez-Jimenez, R, Sukhai, R N, Oostdijk, W, Bakker, B, Reeser, H M, Ballieux, B E P B, Hu, P, Klaassen, E S, Freijer, J, Burggraaf, J, Cohen, A F & Wit, J M 2013, ' Pharmacokinetics and pharmacodynamics of orally administered clonidine : A model-based approach ', Hormone Research in Paediatrics, vol. 79, no. 5, pp. 300-309 . https://doi.org/10.1159/000350819
Hormone Research in Paediatrics, 79(5), 300-309. S. Karger AG
Background/Aims: The oral clonidine test is a diagnostic procedure performed in children with suspected growth hormone (GH) deficiency. It is associated with untoward effects, including bradycardia, hypotension and sedation. Serum clonidine levels ha
Autor:
Joana E. Kist-van Holthe, Zheng Guan, Nynke Teeninga, Teun van Gelder, Mariëtte T. Ackermans, An F. C. Ruiter, Jan Freijer, Jeroen Nauta
Publikováno v:
Therapeutic Drug Monitoring, 34(4), 485-492. Lippincott Williams & Wilkins
Therapeutic Drug Monitoring, 35(4), 485-492. Lippincott Williams and Wilkins
Therapeutic drug monitoring, 35(4), 485-492. Lippincott Williams and Wilkins
Teeninga, N, Guan, Z, Freijer, J, Ruiter, A F C, Ackermans, M T, Kist-van Holthe, J E, van Gelder, T & Nauta, J 2013, ' Monitoring Prednisolone and Prednisone in Saliva: A Population Pharmacokinetic Approach in Healthy Volunteers ', Therapeutic Drug Monitoring, vol. 35, no. 4, pp. 485-492 . https://doi.org/10.1097/FTD.0b013e3182899ea2
Therapeutic Drug Monitoring, 35(4), 485-492. Lippincott Williams and Wilkins
Therapeutic drug monitoring, 35(4), 485-492. Lippincott Williams and Wilkins
Teeninga, N, Guan, Z, Freijer, J, Ruiter, A F C, Ackermans, M T, Kist-van Holthe, J E, van Gelder, T & Nauta, J 2013, ' Monitoring Prednisolone and Prednisone in Saliva: A Population Pharmacokinetic Approach in Healthy Volunteers ', Therapeutic Drug Monitoring, vol. 35, no. 4, pp. 485-492 . https://doi.org/10.1097/FTD.0b013e3182899ea2
BACKGROUND: Prednisolone (PLN) is a widely used corticosteroid in a variety of immune-mediated diseases. Treatment regimes generally consist of empirically derived treatment doses, whereas therapeutic response among patients is highly variable. Drug
Autor:
Astrid Lipplaa, Jan Freijer, Tim L. Beumer, Lennard B. Karger, Joop M. A. van Gerven, Johan G. C. van Hasselt, Marieke L. de Kam, Linda E. Klumpers, H. Daniël Kleinloog
Publikováno v:
British Journal of Clinical Pharmacology. 74:42-53
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Cannabis based medicines are registered as a treatment for various indications, such as pain and spasms in multiple sclerosis (MS) patients, and anorexia and nausea in patients with HIV or receiving cancer
Publikováno v:
British Journal of Pharmacology. 154:1369-1378
Background and purpose: The pharmacokinetic–pharmacodynamic (PK–PD) correlation of fluvoxamine 5-HT transporter (SERT) occupancy was determined in rat frontal cortex ex vivo. Experimental approach: Rats (n=47) with permanent arterial and venous c